The possible mechanisms of DPP-4 inhibitors for treatment of DKD is a proximally acting natriuresis that increases sodium excretion and triggers tubuloglomerular feedback (Crajoinas et al., 2011). The gene discussed is DPP4; the disease is diabetic kidney disease.